Infrared-Mediated Drug Elution Activity of Gold Nanorod-Grafted TiO 2

The purpose of this research was to prepare gold nanorod- (GNR-) grafted TiO2 nanotubes by thiolactic acid treatment and evaluate remote-controlled drug elution and antibacterial activity by infrared (IR) light irradiation. Tetracycline used as an antibiotic was loaded into GNR-grafted TiO2 nanotubes by using 2 w/v% polylactic acid solutions. A near-IR laser (830 nm) was used for remote-controlled IR light irradiation. Results of SEM, TEM, XRD, and EDX revealed that GNR chemically bonded to the whole surface of the TiO2 nanotubes. An antibiotic release test revealed that on-off drug elution was triggered effectively by the photothermal effect of GNR grafted on TiO2 nanotubes. Furthermore, an antibacterial agar zone test indicated that the annihilated zone of Streptococcus mutans in the experimental group with IR light irradiation was significantly larger than that of the corresponding group without IR light irradiation (P<0.05). Therefore, GNR-grafted TiO2 nanotubes would be expected to extend the limited usage of TiO2, which show photocatalytic activity only within the ultraviolet (UV) to IR region, thereby allowing the development of novel fusion technologies in the field of implant materials

A study of hepatitis B virus reactivation associated with rituximab therapy in real-world clinical practice: a single-center experience

Background/AimsThe widespread use of cytotoxic chemotherapy and immunosuppressants has resulted in reactivation of hepatitis B virus (HBV) recently becoming an issue. Although rituximab (an anti-CD20 monoclonal antibody) has revolutionized the treatment of lymphoma, recent reports have suggested that rituximab therapy increases the risk of viral-mediated complications, and particularly HBV reactivation. This study analyzed real clinical practice data for rituximab-related HBV reactivation.MethodsBetween January 2005 and December 2011, 169 patients received treatment with rituximab. Screening status of the HBV infection and frequency of preemptive therapy were determined in these patients, and the clinical features of HBV reactivation were analyzed.ResultsSeventy-nine of the 169 patients with chronic or past HBV infection were selected for evaluation of HBV reactivation. Of the 90 patients who were excluded, 22 (13.0%) were not assessed for HBsAg and anti-HBc, and 14 (8.3%) were not assessed for anti-HBc due to seronegativity for HBsAg. The selected patients were divided into those with chronic HBV infection (n=12) and those with past HBV infection (n=67); six patients (7.6%) experienced HBV reactivation. Eight patients received preemptive therapy, but three patients (37.5%) underwent HBV reactivation. Although HBsAg seropositivity was an independent risk factor for HBV reactivation (P=0.038), of the six patients with HBV reactivation, two (33.3%) had past HBV infection and three (50%) died of liver failure.ConclusionsThe findings of this study demonstrate that adherence to guidelines for screening and preemptive therapy for HBV reactivation was negligent among the included cohort. Attention should be paid to HBV reactivation in patients with past as well as chronic HBV infection during and after rituximab therapy

A case of peripheral gangrene and osteomyelitis secondary to terlipressin therapy in advanced liver disease

Variceal bleeding and hepatorenal syndrome (HRS) are serious and life-threatening complications of advanced liver disease. Terlipressin is widely used to manage both acute variceal bleeding and HRS due to its potency and long duration of action. The most severe (though rare) adverse event is ischemia. The present report describes the case of a patient with gangrene and osteomyelitis secondary to terlipressin therapy. A 71-year-old male with alcoholic liver cirrhosis (Child-Pugh B) and chronic hepatitis C was admitted due to a drowsy mental status. The patient had several experiences of orthopedic surgery. His creatinine level had gradually elevated to 4.02 mg/dL, and his urine output decreased to 500 mL/24 hr. The patient was diagnosed as having grade III hepatic encephalopathy (HE) and type II HRS. Terlipressin and albumin were administered intravenously to treat the HRS over 11 days. Although he recovered from the HE and HRS, the patient developed peripheral gangrene and osteomyelitis in both feet. His right toes were cured with the aid of rescue therapy, but his left three toes had to be amputated. Peripheral gangrene and osteomyelitis secondary to terlipressin therapy occur only rarely, and there is no specific rescue therapy for these conditions. Thus, attention should be paid to the possibility of ischemia of the skin and bone during or after terlipressin therapy

Improved Chest Anomaly Localization without Pixel-level Annotation via Image Translation Network Application in Pseudo-paired Registration Domain

Image translation based on a generative adversarial network (GAN-IT) is a promising method for the precise localization of abnormal regions in chest X-ray images (AL-CXR) even without pixel-level annotation. However, heterogeneous unpaired datasets undermine existing methods to extract key features and distinguish normal from abnormal cases, resulting in inaccurate and unstable AL-CXR. To address this problem, we propose an improved two-stage GAN-IT involving registration and data augmentation. For the first stage, we introduce an advanced deep-learning-based registration technique that virtually and reasonably converts unpaired data into paired data for learning registration maps, by sequentially utilizing linear-based global and uniform coordinate transformation and AI-based non-linear coordinate fine-tuning. This approach enables the independent and complex coordinate transformation of each detailed location of the lung while recognizing the entire lung structure, thereby achieving higher registration performance with resolving inherent artifacts caused by unpaired conditions. For the second stage, we apply data augmentation to diversify anomaly locations by swapping the left and right lung regions on the uniform registered frames, further improving the performance by alleviating imbalance in data distribution showing left and right lung lesions. The proposed method is model agnostic and shows consistent AL-CXR performance improvement in representative AI models. Therefore, we believe GAN-IT for AL-CXR can be clinically implemented by using our basis framework, even if learning data are scarce or difficult for the pixel-level disease annotation

An Integrative Approach to Treat Parkinson's Disease: Ukgansan Complements L-Dopa by Ameliorating Dopaminergic Neuronal Damage and L-Dopa-Induced Dyskinesia in Mice

Parkinson's disease (PD) is accompanied by motor impairments due to the loss of dopaminergic neurons in the nigrostriatal pathway. Levodopa (L-dopa) has been the gold standard therapy for PD since the 1960s; however, its neurotoxic features accelerate PD progression through auto-oxidation or the induction of dyskinetic movements. Ukgansan (UGS) is a well-known prescription for treating PD in traditional medicines of East Asia, and its anti-PD function has been experimentally evaluated. The present study investigated whether UGS attenuates (1) motor dysfunction and dopaminergic neuronal damage when co-treated with L-dopa and (2) L-dopa-induced dyskinesia (LID) in 6-hydroxydopamine (6-OHDA)-induced PD mice. Although L-dopa was found to reduce motor dysfunctions, it failed to decrease the dopaminergic neuronal damage and increased the expression of dopamine receptor 1 (D1R) and 2 (D2R) in the 6-OHDA-injected mouse striatum. Co-treatment with UGS resulted in normal striatal histology and ameliorated motor impairments. In addition, UGS suppressed the dyskinesia induced by chronic L-dopa treatment while restoring the dopaminergic neurons in the striatum. For the underlying mechanism, UGS reduced the overexpression of D1R-related signaling proteins, such as phosphorylated extracellular signal-regulated kinase, ΔFosB, and c-fos in the striatum. Overall, the results suggest that the effect of UGS could be complementary to L-dopa by ameliorating motor dysfunction, restoring the dopaminergic neurons, and suppressing the dyskinetic movements in PD

CReHate: Cross-cultural Re-annotation of English Hate Speech Dataset

English datasets predominantly reflect the perspectives of certain nationalities, which can lead to cultural biases in models and datasets. This is particularly problematic in tasks heavily influenced by subjectivity, such as hate speech detection. To delve into how individuals from different countries perceive hate speech, we introduce CReHate, a cross-cultural re-annotation of the sampled SBIC dataset. This dataset includes annotations from five distinct countries: Australia, Singapore, South Africa, the United Kingdom, and the United States. Our thorough statistical analysis highlights significant differences based on nationality, with only 59.4% of the samples achieving consensus among all countries. We also introduce a culturally sensitive hate speech classifier via transfer learning, adept at capturing perspectives of different nationalities. These findings underscore the need to re-evaluate certain aspects of NLP research, especially with regard to the nuanced nature of hate speech in the English language

Efficacy and safety of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma as first-line therapy

Background/AimsHepatic arterial infusion chemotherapy (HAIC) with 5-fluorouracil and cisplatin for intractable advanced hepatocellular carcinoma (HCC) may have survival benefits. We aimed to determine the efficacy and safety of HAIC for advanced HCC as first-line therapy.MethodsA total of 54 patients who received only HAIC with 5-fluorouracil (750 mg/m2 on days 1-4) and cisplatin (25 mg/m2 on days 1-4) for advanced HCC from Jan. 2009 to Dec. 2011 were selected. According to Child-Pugh class, the overall survival (OS), progression-free survival (PFS), and adverse events after HAIC were investigated retrospectively.ResultsMedian OS and PFS between the Child-Pugh A group (n=24) and the Child-Pugh B/C group (n=30) were 8.7 (95% confidence interval [CI]: 4.7-12.7) vs. 3.7 months (95% CI: 2.0-5.3), and 7.1 (95% CI: 3.8-10.4) vs. 3.6 months (95% CI: 2.0-5.2), respectively. Although median OS and PFS were not statistically significant between the two groups (P=0.079, P=0.196), the Child-Pugh class B/C tended to influence poor OS. Serious adverse events ≥ grade 3 occurred frequently in both groups (83.3 vs. 96.7%, P=0.159). Responders (22.2%, complete or partial response) significantly differed in median OS, compared to non-responders (13.1 vs. 4.4 months, P=0.019). Achievement of complete or partial response was an independent prognostic factor of OS (hazard ratio: 0.4, 95% CI: 0.2-0.8, P=0.011).ConclusionsAchievement of response after HAIC provide a survival benefit in patients with advanced HCC, but HAIC should be administered cautiously in patients with Child-Pugh class B/C, because of a relatively low survival and high incidence of serious adverse events

Agaricus blazei Extract Induces Apoptosis through ROS-Dependent JNK Activation Involving the Mitochondrial Pathway and Suppression of Constitutive NF-κB in THP-1 Cells

Agaricus blazei is widely accepted as a traditional medicinal mushroom, and it has been known to exhibit immunostimulatory and anti-cancer activity. However, the apoptotic mechanism in cancer cells is poorly understood. In this study, we have investigated whether A. blazei extract (ABE) exerts antiproliferative and apoptotic effects in human leukemic THP-1 cells. We observed that ABE-induced apoptosis is associated with the mitochondrial pathway, which is mediated by reactive oxygen species (ROS) generation and prolonged c-Jun N-terminal kinase (JNK) activation. In addition, the ABE treatment resulted in the accumulation of cytochrome c in the cytoplasm, an increase in caspase activity, and an upregulation of Bax and Bad. With those results in mind, we found that ABE decreases constitutive NF-κB activation and NF-κB-regulated gene products such as IAP-1 and -2. We concluded that ABE induces apoptosis with ROS-dependent JNK activation and constitutive activated NF-κB inhibition in THP-1 cells

Cell-free synthesis of functional phospholipase A1 from Serratia sp.

Additional file 1: Figure S1 Gas chromatography analysis of sesame oil incubated with cell-free synthesized PLA1